{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-001905","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2026-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.539365+00:00","generated_at":"2026-05-16T10:33:55.917110+00:00","sec_items":["2.02","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Charles River: Q4 DSA book-to-bill ~1.1x; acquires K.F. (Cambodia) for $510M and PathoQuest for ~$60M","bullets":["Preliminary Q4 DSA net book-to-bill ~1.1x, driven by improved demand from small/mid biotech and global biopharma in Q4.","2026 organic revenue guidance expects at least flat growth for consolidated and DSA, with revenue growth returning in H2 2026.","Non-GAAP operating margin outlook includes >$100M in incremental cost savings to offset inflation until revenue growth resumes.","Acquiring K.F. (Cambodia) for ~$510M; accretive $0.25 in 2026, $0.60 in 2027; close expected early Q1 2026.","Exercising option to buy remaining 79% of PathoQuest for ~€51.6M (~$60M); close by end Q1 2026, not material to 2026/2027 results."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-001905","json":"https://secwatch.observer/filing/0001628280-26-001905.json","markdown":"https://secwatch.observer/filing/0001628280-26-001905.md","text":"https://secwatch.observer/filing/0001628280-26-001905.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000162828026001905/0001628280-26-001905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000162828026001905/crl-20260113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:33:55.917110+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}